Orchestra BioMed Publishes AVIM Therapy Clinical Data In JACC: Advances
Benzinga Newsdesk 1 year ago
BiotechNewsGeneral
Echocardiographic data analysis demonstrated favorable impact of atrioventricular interval modulation ("AVIM") therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart
- Echocardiographic data analysis demonstrated favorable impact of atrioventricular interval modulation ("AVIM") therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart failure with preserved ejection fraction ("HFpEF")
- Hypertension is the leading cause of diastolic dysfunction and the most common comorbidity in older patients indicated for a pacemaker